MedPath

effect of montelukast in athma exacerbatio

Phase 3
Recruiting
Conditions
Asthma exacerbation.
Moderate persistent asthma with (acute) exacerbation
J45.41
Registration Number
IRCT20171227038108N1
Lead Sponsor
Research and Technology dept of Mazandaran University Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

Age of 18 -65 years old
Known case of asthma
Impersion of asthma exacerbation at time of addmision

Exclusion Criteria

Intubation at time of addmision
Other cause of pulmunary disease for example pneumonia
Pregnancy and lactation
History of hypersensitivity to montelukast
Drug history of phenytoin,rifampin,phenobarbital
History of smoking more than 20 pack/years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulmonary function tast. Timepoint: 1,3,5 day’s of addmition. Method of measurement: spirometry,peak flowmetry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath